Quantum Biopharma (QNTM) Net Income towards Common Stockholders (QoQ) (2019 - 2026)
Quantum Biopharma (QNTM) Net Income towards Common Stockholders (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Quantum Biopharma | 13.11 Bn | 13.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.92% |
| Dec 31, 2025 | 51.76% |
| Sep 30, 2025 | 4.04% |
| Jun 30, 2025 | -45.21% |
| Mar 31, 2025 | -63.51% |
| Dec 31, 2024 | 50.06% |
| Sep 30, 2024 | -20.97% |
| Jun 30, 2024 | -52.66% |
| Jun 30, 2021 | -184.84% |
| Sep 30, 2020 | -184.13% |
| Jun 30, 2020 | 54.39% |
| Mar 31, 2020 | 92.27% |
| Dec 31, 2019 | -579.78% |
| Sep 30, 2019 | -44.17% |
| Jun 30, 2019 | -39.22% |